# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Rockwell Medical (NASDAQ:RMTI) affirms FY2025 sales outlook from $65.000 million-$70.000 million to $65.000 million-$70.000 mil...
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0....